MediWound Reports First Quarter 2020 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- AMD shares fall amid AI chip sector selloff
- Alphabet shares drop ahead of earnings next week
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
MediWound (MDWD) Tops Q1 EPS by 5c, Revenues Beat
May 20, 2020 7:04 AM EDTMediWound (NASDAQ: MDWD) reported Q1 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $4.05 million.
First Quarter Business and Financial Highlights:
Total revenues for the first quarter of 2020 were $4.4 millionOperating loss for the first quarter of 2020 was $2.2 million, representing a 38% decrease compared to prior-year periodOperating cash flow was $2.1 million, and as of March 31, 2020, the company had $27.3 million in cash and short-term investmentsSubsequent to the end of the quarter, the Company resumed patient... More


